Abstract
No public abstract is available from the verified source records.
S. S. Kapoor, Deepak Verma
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Deep learning with differential privacy
2016
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
10.1038/ncomms5006 · 2014
Unresolved referenced work
2019
A gentle introduction to conformal prediction and distribution-free uncertainty quantification
2021
The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design
10.1513/annalsats.202003-192sd · 2020
Statistical modeling of clinical trials (recruitment and randomization)
10.1080/03610926.2011.581189 · 2011
10.1002/sim.2956
10.1002/sim.2956
Recursive partitioning for heterogeneous causal effects
10.1073/pnas.1510489113 · 2016
10.1080/00273171.2011.568786
10.1080/00273171.2011.568786
An empirical evaluation of generic convolutional and recurrent networks for sequence modeling
2018
Unresolved referenced work
Kept as external metadata until matched
Multimodal machine learning: a survey and taxonomy
10.1109/tpami.2018.2798607 · 2019
10.18653/v1/d19-1371
10.18653/v1/d19-1371
AstraZeneca-BenevolentAI collaboration productivity update. BenevolentAI FY2022/FY2023 Annual Reports
2022
10.1038/nrd1927
10.1038/nrd1927
Adaptive clinical trials: the promise and the caution
10.1200/jco.2010.32.2685 · 2011
10.1007/s43441-020-00209-0
10.1007/s43441-020-00209-0
Time series deconfounder: estimating treatment effects over time in the presence of hidden confounders
2020
Unresolved referenced work
Kept as external metadata until matched
Practical secure aggregation for privacy-preserving machine learning
2017
Applications of quantitative systems pharmacology in model-informed drug discovery: perspective on impact and opportunities
10.1002/psp4.12463 · 2019
Random forests
10.1023/a:1010933404324 · 2001
Generative adversarial networks in time series: a systematic literature review
10.1145/3559540 · 2023
Multitask learning
10.1023/a:1007379606734 · 1997
Fairness in machine learning: a survey
10.1145/3616865 · 2024
Classification with fairness constraints: a meta-algorithm with provable guarantees
2019
Anomaly detection: a survey
10.1145/1541880.1541882 · 2009
Deep learning with multimodal representation for pancancer prognosis prediction
10.1093/bioinformatics/btz342 · 2019
XGBoost: a scalable tree boosting system
2016
Double/debiased machine learning for treatment and structural parameters
10.1111/ectj.12097 · 2018
Unresolved referenced work
2017
An economic approach to clinical trial design and research priority-setting
10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · 1996
Unresolved referenced work
2014
An economic perspective on platform trials—the gift and the curse
10.1001/jamanetworkopen.2022.21149 · 2022
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
10.1136/bmj-2023-078378 · 2024
Real-world evidence and real-world data for evaluating drug safety and effectiveness
10.1001/jama.2018.10136 · 2018
Unresolved referenced work
Kept as external metadata until matched
Federated learning for predicting clinical outcomes in patients with COVID-19
10.1038/s41591-021-01506-3 · 2021
Unresolved referenced work
2019
10.18653/v1/n19-1423
10.18653/v1/n19-1423
Modeling polypharmacy side effects with graph convolutional networks
10.1093/bioinformatics/bty294 · doi-reference
10.1002/cpt.1475
10.1002/cpt.1475 · doi-reference
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
10.1038/s41587-019-0224-x · doi-reference
10.1080/01621459.2012.695674
10.1080/01621459.2012.695674 · doi-reference
Robust variable selection methods with Cox model—a selective practical benchmark study
10.1093/bib/bbae508 · doi-reference
10.1056/nejmsa1012065
10.1056/nejmsa1012065 · doi-reference
10.1158/1078-0432.ccr-16-0592
10.1158/1078-0432.ccr-16-0592 · doi-reference
Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding
10.1093/annonc/mdx795 · doi-reference
Estimated research and development investment needed to bring a new medicine to market, 2009-2018
10.1001/jama.2020.1166 · doi-reference
Master protocols to study multiple therapies, multiple diseases, or both
10.1056/nejmra1510062 · doi-reference
Estimation of clinical trial success rates and related parameters
10.1093/biostatistics/kxy072 · doi-reference
Marginal structural models in clinical research: when and how to use them?
10.1093/ndt/gfw341 · doi-reference
The FAIR guiding principles for scientific data management and stewardship
10.1038/sdata.2016.18 · doi-reference
Do no harm: a roadmap for responsible machine learning for health care
10.1038/s41591-019-0548-6 · doi-reference
Doubly robust estimation in causal inference with missing outcomes: with an application to the Aerobics Center Longitudinal Study
10.1016/j.csda.2021.107399 · doi-reference
I-SPY 2: a neoadjuvant adaptive clinical trial designed to improve outcomes in high-risk breast cancer
10.1007/s12609-019-00334-2 · doi-reference
Applications of deep learning in molecule generation and molecular property prediction
10.1021/acs.accounts.0c00699 · doi-reference
Estimation and inference of heterogeneous treatment effects using random forests
10.1080/01621459.2017.1319839 · doi-reference
Decision curve analysis to evaluate the clinical benefit of prediction models
10.1016/j.spinee.2021.02.024 · doi-reference
10.1186/s41512-019-0064-7
10.1186/s41512-019-0064-7 · doi-reference
10.1177/0272989x211068019
10.1177/0272989x211068019 · doi-reference
Decoding the genetic symphony: profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights
10.1093/pnasnexus/pgae011 · doi-reference
Machine learning for medical imaging: methodological failures and recommendations for the future
10.1038/s41746-022-00592-y · doi-reference
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: the Apple Heart Study
10.1016/j.ahj.2018.09.002 · doi-reference
Comment: advancing clinical trials with novel designs and implementations
10.1214/23-sts865c · doi-reference
The personal and clinical utility of polygenic risk scores
10.1038/s41576-018-0018-x · doi-reference
Regression shrinkage and selection via the Lasso: a retrospective
10.1111/j.1467-9868.2011.00771.x · doi-reference
On the likelihood that one unknown probability exceeds another in view of the evidence of two samples
10.1093/biomet/25.3-4.285 · doi-reference
Adaptive enrichment designs in clinical trials
10.1146/annurev-statistics-040720-032818 · doi-reference
A scoping review of artificial intelligence applications in clinical trial risk assessment
10.1038/s41746-025-01886-7 · doi-reference
k-anonymity: a model for protecting privacy
10.1142/s0218488502001648 · doi-reference
10.1186/s12874-016-0272-6
10.1186/s12874-016-0272-6 · doi-reference
A scoping review and assessment framework for technical debt in the development and operation of AI/ML competition platforms
10.3390/app15137165 · doi-reference
Deep EHR: a survey of recent advances in deep learning techniques for electronic health record (EHR) analysis
10.1109/jbhi.2017.2767063 · doi-reference
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint
10.1038/s41598-024-80177-9 · doi-reference
Costs of drug development and research and development intensity in the US, 2000-2018
10.1001/jamanetworkopen.2024.15445 · doi-reference
An update on knowledge graphs and their current and potential applications in drug discovery
10.1080/17460441.2025.2490253 · doi-reference
Artificial Intelligence and the future of clinical trials
10.1016/j.conctc.2025.101545 · doi-reference
A modern Bayesian look at the multi-armed bandit
10.1002/asmb.874 · doi-reference
Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)
10.1016/j.drudis.2025.104291 · doi-reference